Why the study?
Whether discontinuing versus continuing ACE inhibitors or ARBs on the morning of surgery reduces perioperative hypotension in older patients undergoing non-cardiac surgery was uncertain.
Population
2036 older patients (60-80 years) on ACE inhibitors or ARBs scheduled for non-cardiac surgery in China
Comparison
Placebo (discontinuing) vs usual ACE inhibitor or ARB on the morning of surgery
Design
Multicentre, randomised, double-blind, placebo-controlled trial
Follow-up
30 days
Answers are grounded in this paper and cite their sources.
Supports withholding ACE inhibitors or ARBs on surgery morning in older adults; extends randomized evidence for perioperative hemodynamic optimization.
Objective To determine whether discontinuing versus continuing angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) on the morning of surgery reduces perioperative hypotension in older patients undergoing non-cardiac surgery. Design Multicentre, randomised, double blind, placebo controlled trial. Setting Five tertiary teaching hospitals in China, November 2020 to December 2023. Participants 2036 older patients (60-80 years) using ACE inhibitors or ARBs for at least two weeks and scheduled for non-cardiac surgery under general anaesthesia. Interventions Patients were randomised to receive their usual ACE inhibitor or ARB or a placebo in identical capsules on the morning of surgery. Main outcome measures The primary outcome was the incidence of perioperative hypotension (mean blood pressure <65 mm Hg or a =30% decrease from baseline requiring treatment). Secondary outcomes included duration of hypotension, requirement for a vasopressor, intraoperative fluid volume, postoperative hypotension, and 30 day complications (neurocognitive disorders, major cardiocerebral events) or mortality. Results 2012 patients (mean age 68.8 years; 54.4% male) completed the study: 1004 were included in the antihypertensive group and 1008 in the no antihypertensive group. The incidence of perioperative hypotension was lower in the no antihypertensive group (314/1008, 31.2%) versus antihypertensive group (457/1004, 45.5%): adjusted odds ratio 0.52 (95% confidence interval (CI) 0.43 to 0.63); absolute risk difference -14.4% (95% CI -18.5% to -10.1%); P<0.001. The duration of hypotension and requirement for a vasopressor were both reduced in the no antihypertensive group: adjusted mean difference -1.3 minutes (95% CI -1.8 to -0.8 minutes) and 28.5% v 41.1%; adjusted odds ratio 0.54 (95% CI 0.44 to 0.66). Intraoperative fluid volume, postoperative hypotension, 30 day complications, and mortality did not differ significantly between groups. Conclusions Discontinuing ACE inhibitors or ARBs on the morning of surgery in older patients with hypertension statistically significantly reduced perioperative hypotension and the requirement for vasopressors without increasing 30 day complications or mortality. This simple strategy provides high certainty evidence for preoperative drug management in this patient population. Trial registration Chinese Clinical Trial Registry NCT2000039376 .
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: